Brief: Ultimovacs Announces Publication Of Phase II Focus Trial Results On Medrxiv

Zelluna ASA

25/10/2024 16:02

Oct 25 (Reuters) - Ultimovacs ASA  ULTI.OL :
    * ANNOUNCES PUBLICATION OF PHASE II FOCUS TRIAL RESULTS ON
MEDRXIV
    * STUDY THEREFORE DID NOT MEET ITS PRIMARY AND SECONDARY
ENDPOINTS
    * UV1 CONTINUED TO DEMONSTRATE POSITIVE SAFETY PROFILE IN
LINE
WITH OTHER UV1 STUDIES

Source text for Eikon:  ID:nObifNB40a 
Further company coverage:  ULTI.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))